A 5-Question Quiz on Breast Cancer

Article

Do you know the prevalence of triple-negative breast cancer? How about the patient makeup in the START A and START B trials, which tested hypofractionated radiotherapy for breast cancer? Answer these questions and more.

Question 1:

Answer and Question 2 on Next Page »

The correct answer is D. Refer to medical oncologist to discuss an anti-estrogen risk reduction agent (eg, tamoxifen)

Question 2:

Answer and Question 3 on Next Page »

The correct answer is D. Some women with ductal carcinoma in situ were included in these trials

Question 3:

Answer and Question 4 on Next Page »

The correct answer is B. 15% to 20%

Question 4:

Answer and Question 5 on Next Page »

The correct answer is A. The majority of tumors are estrogen-receptor positive

Question 5:

Answer on Next Page »

The correct answer is D. Germline BRCA1- or BRCA2-mutated tumor

 

Related Videos
A panel of 4 experts on multiple myeloma
A panel of 4 experts on lung cancer
A panel of 4 experts on multiple myeloma
A panel of 4 experts on lung cancer
Video 8 - "Closing Thoughts on the Future of NSCLC"
Video 7 - "Molecular Testing: Key Takeaways on Next Generation Sequencing in NSCLC "
Samer A. Al'Hadidi, MD, with Rahul Gosain, MD, and Rohit Gosain, MD
Samer A. Al'Hadidi, MD, with Rahul Gosain, MD, and Rohit Gosain, MD
Samer A. Al'Hadidi, MD, with Rahul Gosain, MD, and Rohit Gosain, MD
Samer A. Al'Hadidi, MD, with Rahul Gosain, MD, and Rohit Gosain, MD